Orchestra BioMed Holdings, Inc. ( OBIO) - Key Metrics
OBIO Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$0.37 | -$0.30 | -$0.31 |
| 2026Q1 | $0 | -$0.33 | -$0.35 | -$0.36 |
| 2025Q4 | $0.62 | $0.12 | -$0.05 | -$0.05 |
| 2025Q3 | $0.02 | -$0.40 | -$0.28 | -$0.28 |
| 2025Q2 | $0.02 | -$0.50 | -$0.40 | -$0.41 |
OBIO Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -2.84 |
| 2026Q1 | 0% | -3.22 |
| 2025Q4 | 0% | 8.65 |
| 2025Q3 | 0% | -1.55 |
| 2025Q2 | 0% | -1.34 |
OBIO
Price: $5.47
52 week price:
Earnings Per Share: -0.84 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 265.1 million